Terumo (OTCMKTS:TRUMY) Shares Gap Down – What’s Next?

Shares of Terumo Corp. (OTCMKTS:TRUMY) gapped down prior to trading on Thursday . The stock had previously closed at $13.09, but opened at $12.5101. Terumo shares last traded at $12.9315, with a volume of 916,960 shares changing hands.

Terumo Stock Performance

The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.46 and a current ratio of 2.51. The business’s fifty day moving average price is $14.57 and its two-hundred day moving average price is $16.14. The stock has a market capitalization of $19.28 billion, a P/E ratio of 21.78 and a beta of 0.75.

Terumo (OTCMKTS:TRUMY) last issued its quarterly earnings results on Wednesday, November 12th. The company reported $0.16 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.16. Terumo had a return on equity of 9.39% and a net margin of 12.35%.The company had revenue of $1.86 billion for the quarter, compared to analyst estimates of $1.75 billion.

About Terumo

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.